3rd Annual NASH Summit | April 22-25, 2019 | Boston, MA
April 22 - 25, 2019 - Boston MA USHanson Wade
info@hansonwade.com
Phone:617 455 4188
Be at the forefront of the insights from 60+ leading experts as they share their learnings on: Commercialization challenges, the payers perspective and the investors’ criteria for business in the current and future NASH market The non-invasive diagnostics landscape and regulatory considerations on biomarker adoption for clinical trials Computational methods and artificial intelligence to increase the efficiency of drug development Scientific rationale of combinational therapeutics as the necessary treatment strategy for NASH to inform pairing decisions Identification and recruitment of “high risk” patients needed to optimize clinical success and demonstrate sufficient efficacy